Today: 23 January 2026
Subscribe
Browse Category

Pharmaceuticals News 26 December 2025 - 29 December 2025

Eli Lilly stock steadies into Monday as $55 million ABL Bio funding keeps pipeline in focus

Eli Lilly stock steadies into Monday as $55 million ABL Bio funding keeps pipeline in focus

NEW YORK, December 28, 2025, 20:34 ET — Market closed Eli Lilly shares ended the holiday week little changed after South Korean biotech ABL Bio said it would receive $55 million in funding from the U.S. drugmaker under a research collaboration. PR Newswire The funding is small by Lilly standards, but it underscores how closely investors are tracking the company’s…
29 December 2025
····
Johnson & Johnson stock (JNJ) holds near $208 as J&J halts eczema trial; what investors should watch before Monday’s open

Johnson & Johnson stock (JNJ) holds near $208 as J&J halts eczema trial; what investors should watch before Monday’s open

NEW YORK, Dec. 28, 2025, 3:26 p.m. ET — Market closed Johnson & Johnson stock (NYSE: JNJ) heads into the final trading week of 2025 with U.S. markets shut for the weekend and investors sorting through a fresh pipeline headline that surfaced late Friday. With the New York Stock Exchange closed today and the next regular session set for Monday,…
28 December 2025
····
Merck (MRK) Stock Today: Latest News, Analyst Forecasts, and What Investors Should Watch Before Monday’s Open

Merck (MRK) Stock Today: Latest News, Analyst Forecasts, and What Investors Should Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 11:52 a.m. ET — Market Closed Merck & Co., Inc. (NYSE: MRK) heads into the final trading days of 2025 with shares hovering near fresh highs after a late-December climb that has put the pharmaceutical giant back in the spotlight for both defensive investors and catalyst-driven traders. With U.S. stock markets closed for the weekend,…
28 December 2025
····
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open

NEW YORK, Dec. 28, 2025, 6:44 a.m. ET — Market closed Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) heads into the final trading days of 2025 with investors trying to separate two very different realities: an explosive year-to-date run that put the breast-cancer biotech firmly on the growth-stock map—and a sharp late-December pullback that has reset near-term expectations. With U.S. markets closed…
28 December 2025
····
Eli Lilly Stock (LLY) Outlook for Monday: Latest Deal Headlines, GLP-1 Pill Race, and Wall Street Targets

Eli Lilly Stock (LLY) Outlook for Monday: Latest Deal Headlines, GLP-1 Pill Race, and Wall Street Targets

NEW YORK, Dec. 28, 2025, 12:25 a.m. ET — Market closed. Eli Lilly and Company (NYSE: LLY) heads into the final trading stretch of 2025 with its stock near record territory and investors laser-focused on three forces that can move the shares quickly: (1) the accelerating battle for obesity and diabetes drug dominance, (2) the policy and pricing machinery starting…
28 December 2025
···
Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus

Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus

NEW YORK, Dec. 27, 2025, 3:33 PM ET — Market closed Johnson & Johnson (NYSE: JNJ) stock is heading into the final trading days of 2025 with U.S. markets closed for the weekend and year-end liquidity typically thinning across Wall Street. JNJ last closed at $207.63 on Friday, down 0.07% on the day, and was last indicated around $207.86 in…
27 December 2025
····
Merck (MRK) Stock Update: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Analyst Targets as Wall Street Heads Into New Year Week

Merck (MRK) Stock Update: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Analyst Targets as Wall Street Heads Into New Year Week

As of 10:40 p.m. ET in New York on Friday, Dec. 26, 2025, U.S. markets have wrapped up the post-Christmas session and are heading into a weekend — leaving investors to digest a fresh cluster of headline catalysts around Merck & Co., Inc. (NYSE: MRK) before the next opening bell. Merck shares finished the regular session around $106.78, after trading…
27 December 2025
····
Eli Lilly Stock (LLY) Holds Near $1,078 After Friday’s Close as GLP‑1 Pricing, Pill Competition, and Retatrutide Data Shape the 2026 Outlook

Eli Lilly Stock (LLY) Holds Near $1,078 After Friday’s Close as GLP‑1 Pricing, Pill Competition, and Retatrutide Data Shape the 2026 Outlook

New York — As of 7:56 p.m. ET on Friday, December 26, 2025, Eli Lilly and Company (NYSE: LLY) is coming off a session that left the stock hovering around $1,077.75, essentially flat on the day after a narrow trading range. With U.S. markets now shut for the weekend, the next major read for investors will come when trading resumes…
27 December 2025
···
Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

Eli Lilly Stock (LLY) Today: GLP‑1 Price Cuts, the Obesity Pill Race, and What Investors Are Watching Into 2026

New York — Friday, December 26, 2025 (2:28 p.m. ET): Eli Lilly and Company (NYSE: LLY) is trading near $1,075 per share, essentially flat to slightly lower on the day in a thin, post‑Christmas U.S. session where the major indexes are hovering close to record levels. Reuters For investors, the timing matters: holiday trading often amplifies short‑term moves and can…
26 December 2025
····
GSK plc Stock (NYSE: GSK, LSE: GSK): Latest News, Forecasts, and Key Catalysts as of Dec. 26, 2025

GSK plc Stock (NYSE: GSK, LSE: GSK): Latest News, Forecasts, and Key Catalysts as of Dec. 26, 2025

December 26, 2025 — GSK plc stock is closing out the year with a familiar mix of “defensive pharma stability” and “pipeline-driven volatility.” The past two weeks delivered a cluster of headline-worthy updates: a U.S. FDA approval for GSK’s twice-yearly asthma biologic, a high-profile U.S. drug-pricing agreement that directly touches GSK’s respiratory franchise, regulatory momentum for expanded vaccine use in…
26 December 2025
···
Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025

Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025

U.S. stock markets were closed for Christmas Day (Thursday, Dec. 25, 2025) and are scheduled to reopen Friday, Dec. 26 after a holiday-early close on Wednesday, Dec. 24. New York Stock Exchange That timing matters for Merck & Co., Inc. (NYSE: MRK) investors because the stock has been moving on a cluster of late-December headlines—ranging from drug-pricing policy to pipeline…
26 December 2025
····
Eli Lilly (LLY) Stock: Key News, Catalysts, Forecasts and Risks to Watch Before the Dec. 26, 2025 Market Open

Eli Lilly (LLY) Stock: Key News, Catalysts, Forecasts and Risks to Watch Before the Dec. 26, 2025 Market Open

Eli Lilly and Company (NYSE: LLY) heads into the Friday, Dec. 26, 2025 U.S. market open with investors balancing two powerful forces: policy-driven price pressure on GLP‑1 drugs and pipeline-driven growth potential that keeps Lilly at the center of the obesity and diabetes mega-trend. Because Christmas Day (Dec. 25) is a market holiday and Christmas Eve (Dec. 24) was an…
26 December 2025
····
1 … 19 20 21 22 23 … 46

Stock Market Today

  • StubHub IPO lawsuit deadline nears as investors challenge cash flow disclosures
    January 22, 2026, 7:21 PM EST. Investors have until Jan. 23 to seek lead-plaintiff status in a lawsuit over StubHub's September IPO. The suit alleges the company and its executives, alongside underwriters like J.P. Morgan and Goldman Sachs, misled shareholders by not disclosing shifts in vendor payment timing that worsened free cash flow, a key financial metric measuring cash generated after operational costs. StubHub's free cash flow dropped to negative $4.6 million in the quarter ending Sept. 30, down from a positive $10.6 million a year earlier. The stock trades at around $15, well below its $23.50 IPO price. The case is in early stages, with StubHub citing timing effects as reasons for the cash flow changes. Legal teams are actively seeking investors to represent the class action in court.
Go toTop